Literature DB >> 2456272

Conservation of protective and nonprotective epitopes in M proteins of group A streptococci.

L Miller1, V Burdett, T P Poirier, L D Gray, E H Beachey, M A Kehoe.   

Abstract

Carefully controlled hybridization experiments with probes from a cloned serotype 5 M protein (M5) gene (smp5) were performed with DNA isolated from heterologous M types of group A streptococci, and the homologies detected by hybridization were compared with the ability of anti-pepM5 serum to cross-opsonize heterologous M types. As previously reported (J.R. Scott, S.K. Hollingshead, and V.A. Fischetti, Infect. Immun. 52:609-612, 1986), extensive structural homologies exist among the 3' ends of heterologous M protein genes, but there appears to be an increase in sequence variation as one moves towards the 5' ends. However, a clear, predictive correlation between the hybridization patterns and cross-opsonization was not observed. Antibodies raised to a synthetic peptide corresponding to central, conserved sequences adjacent to the C-terminal sides of the pepsin cleavage sites in M5, serotype 6 M protein, and serotype 24 M protein cross-reacted with heterologous acid-extracted M antigens but were not protective and did not bind to intact streptococcal cells, indicating that these epitopes are inaccessible on the intact cell surface. Removal of the N-terminal half of M5, serotype 6 M protein, or serotype 24 M protein by pepsin exposed the conserved epitope on the cell surface. These results suggest that immunoaccessible protective epitopes are confined to the highly variable N-terminal halves of M proteins and that a single, broadly conserved protective M protein epitope does not exist.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2456272      PMCID: PMC259545          DOI: 10.1128/iai.56.8.2198-2204.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Protective and nonprotective epitopes of chemically synthesized peptides of the NH2-terminal region of type 6 streptococcal M protein.

Authors:  E H Beachey; J M Seyer
Journal:  J Immunol       Date:  1986-03-15       Impact factor: 5.422

2.  Expression of protective and cardiac tissue cross-reactive epitopes of type 5 streptococcal M protein in Escherichia coli.

Authors:  T P Poirier; M A Kehoe; J B Dale; K N Timmis; E H Beachey
Journal:  Infect Immun       Date:  1985-04       Impact factor: 3.441

3.  Homologous regions within M protein genes in group A streptococci of different serotypes.

Authors:  J R Scott; S K Hollingshead; V A Fischetti
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

4.  Unique and common protective epitopes among different serotypes of group A streptococcal M proteins defined with hybridoma antibodies.

Authors:  J B Dale; E H Beachey
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

5.  Epitope-specific protective immunogenicity of chemically synthesized 13-, 18-, and 23-residue peptide fragments of streptococcal M protein.

Authors:  E H Beachey; A Tartar; J M Seyer; L Chedid
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

6.  Complete nucleotide sequence of type 6 M protein of the group A Streptococcus. Repetitive structure and membrane anchor.

Authors:  S K Hollingshead; V A Fischetti; J R Scott
Journal:  J Biol Chem       Date:  1986-02-05       Impact factor: 5.157

7.  Cloning and genetic analysis of serotype 5 M protein determinant of group A streptococci: evidence for multiple copies of the M5 determinant in the Streptococcus pyogenes genome.

Authors:  M A Kehoe; T P Poirier; E H Beachey; K N Timmis
Journal:  Infect Immun       Date:  1985-04       Impact factor: 3.441

8.  Multiple, heart-cross-reactive epitopes of streptococcal M proteins.

Authors:  J B Dale; E H Beachey
Journal:  J Exp Med       Date:  1985-01-01       Impact factor: 14.307

9.  Inhibition of complement-mediated opsonization and phagocytosis of Streptococcus pyogenes by D fragments of fibrinogen and fibrin bound to cell surface M protein.

Authors:  E Whitnack; E H Beachey
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

10.  Epitopes of streptococcal M proteins shared with cardiac myosin.

Authors:  J B Dale; E H Beachey
Journal:  J Exp Med       Date:  1985-08-01       Impact factor: 14.307

View more
  7 in total

1.  The thiol-activated toxin streptolysin O does not require a thiol group for cytolytic activity.

Authors:  M Pinkney; E Beachey; M Kehoe
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

Review 2.  Strategies in the development of vaccines to prevent infections with group A streptococcus.

Authors:  Michael F Good; Michael R Batzloff; Manisha Pandey
Journal:  Hum Vaccin Immunother       Date:  2013-06-28       Impact factor: 3.452

Review 3.  Streptococcal M protein: molecular design and biological behavior.

Authors:  V A Fischetti
Journal:  Clin Microbiol Rev       Date:  1989-07       Impact factor: 26.132

4.  The NH(2)-terminal region of Streptococcus pyogenes M5 protein confers protection against degradation by proteases and enhances mucosal colonization of mice.

Authors:  Thomas A Penfound; Itzhak Ofek; Harry S Courtney; David L Hasty; James B Dale
Journal:  J Infect Dis       Date:  2010-05-15       Impact factor: 5.226

Review 5.  Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope.

Authors:  W W Navarre; O Schneewind
Journal:  Microbiol Mol Biol Rev       Date:  1999-03       Impact factor: 11.056

6.  Application of the polymerase chain reaction to study the M protein(-like) gene family in beta-hemolytic streptococci.

Authors:  A Podbielski; B Melzer; R Lütticken
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

7.  The number of direct repeats in hagA is variable among Porphyromonas gingivalis strains.

Authors:  E Kozarov; J Whitlock; H Dong; E Carrasco; A Progulske-Fox
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.